Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Kunk

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
World Journal of Gastrointestinal Oncology|November 1, 2016
Current debate in the oncologic management of rectal cancerTrish Millard, Paul R Kunk, Erika Ramsdale, et al.
Case Reports in Oncological Medicine|March 3, 2025
Early Detection of Krukenberg Tumors Utilizing ctDNA Testing and CEA MonitoringAngela M DeRidder, Corrine M Check, Paul R Kunk, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
From bench to bedside a comprehensive review of pancreatic cancer immunotherapyPaul R Kunk, Todd W Bauer, Craig L Slingluff, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2016
Direct oral anticoagulants in hypercoagulable statesPaul R Kunk, Jacqueline Brown, Melissa McShane, et al.
American Journal of Clinical Pathology|December 18, 2019
Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive MorphologiesJennifer Y Ju, Megan E Dibbern, Mani S Mahadevan, et al.
Immunotherapy|May 4, 2016
Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumorsRyan Gentzler, Richard Hall, Paul R Kunk, et al.
Journal for Immunotherapy of Cancer|December 30, 2016
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literatureJoshua E Reuss, Paul R Kunk, Anne M Stowman, et al.
Cancer Immunology, Immunotherapy : CII|October 21, 2017
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?Joseph M Obeid, Paul R Kunk, Victor M Zaydfudim, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2018
Risk of Major Bleeding with IbrutinibJoseph Mock, Paul R Kunk, Surabhi Palkimas, et al.
Journal of Healthcare Informatics Research|April 14, 2022
Using Graph Representation Learning to Predict Salivary Cortisol Levels in Pancreatic Cancer PatientsGuimin Dong, Mehdi Boukhechba, Kelly M Shaffer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
World Journal of Gastrointestinal Oncology|November 1, 2016
Current debate in the oncologic management of rectal cancerTrish Millard, Paul R Kunk, Erika Ramsdale, et al.
Case Reports in Oncological Medicine|March 3, 2025
Early Detection of Krukenberg Tumors Utilizing ctDNA Testing and CEA MonitoringAngela M DeRidder, Corrine M Check, Paul R Kunk, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
From bench to bedside a comprehensive review of pancreatic cancer immunotherapyPaul R Kunk, Todd W Bauer, Craig L Slingluff, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2016
Direct oral anticoagulants in hypercoagulable statesPaul R Kunk, Jacqueline Brown, Melissa McShane, et al.
American Journal of Clinical Pathology|December 18, 2019
Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive MorphologiesJennifer Y Ju, Megan E Dibbern, Mani S Mahadevan, et al.
Immunotherapy|May 4, 2016
Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumorsRyan Gentzler, Richard Hall, Paul R Kunk, et al.
Journal for Immunotherapy of Cancer|December 30, 2016
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literatureJoshua E Reuss, Paul R Kunk, Anne M Stowman, et al.
Cancer Immunology, Immunotherapy : CII|October 21, 2017
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?Joseph M Obeid, Paul R Kunk, Victor M Zaydfudim, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2018
Risk of Major Bleeding with IbrutinibJoseph Mock, Paul R Kunk, Surabhi Palkimas, et al.
Journal of Healthcare Informatics Research|April 14, 2022
Using Graph Representation Learning to Predict Salivary Cortisol Levels in Pancreatic Cancer PatientsGuimin Dong, Mehdi Boukhechba, Kelly M Shaffer, et al.
Pageof 2